| Name | (2S)-2-Propylpiperidine hydrochloride (1:1) |
|---|---|
| Synonyms |
(S)-2,2'-bis(diphenylphosphanyl)-5,5'-dichloro-6,6'-dimethoxy-1,1'-biphenyl
(S)-3,7-Dimethyloct-6-enal (3S)-3,7-dimethyl-6-octenal (S)-(+)-coniine*HCl l-citronellal (-)-Citronellal (S)-2-propylpiperidine hydrochloride (S)-(-)-Citronellal (S)-(-)-5,5'-dichloro-6,6'-dimethoxy-2,2'-bis(diphenylphosphino)-1,1'-biphenyl (S)-Cl,OMe-BIPHEP (S)-coniine hydrochloride (3S)-(-)-Citronellal (S)-3,7-Dimethyl-6-octenal (+)-coniine hydrochloride (2S)-2-n-propylpiperidine hydrochloride (R)-Cl,MeO-BIPHEP (+)-(2S)-2-propylpiperidine hydrochloride (S)-Cl-MeO-BIPHEP |
| Description | (±)-Coniine hydrochloride (2-Propylpiperidine hydrochloride) is a potent nAChR agonist with an EC50 value of 0.3 mM. (±)-Coniine hydrochloride shows acute toxicity with an LD50 value of 7.7 mg/kg[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 0.3 mM (nAChR)[1] |
| In Vivo | (±)-Coniine hydrochloride (compound 1) (0.05 mg-0.2 mg; i.v.) 具有急性毒性,LD50 值为 7.7 mg/kg[1]。 Animal Model: 15-20 g, Swiss-Webster male mice[1] Dosage: 0.05 mg-0.2 mg Administration: I.v. Result: Clinical signs was almost immediate after injection, beginning with piloerection, tailflicking, and rapidly progressing to intention tremors, clonic convulsions, muscular weakness, lateral recumbency, and death; shows acute toxicity with an LD50 value of 7.7 mg/kg. |
| References |
| Boiling Point | 166.2ºC at 760 mmHg |
|---|---|
| Melting Point | -210ºC(lit.) |
| Molecular Formula | C8H18ClN |
| Molecular Weight | 163.69 |
| Flash Point | 48.4ºC |
| Exact Mass | 163.11300 |
| PSA | 12.03000 |
| LogP | 3.05940 |
| Vapour Pressure | 1.8mmHg at 25°C |
| Hazard Codes | Xi: Irritant; |
|---|---|
| Risk Phrases | R36 |
| Safety Phrases | S26 |
| HS Code | 2933399090 |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |